Ottava (robot surgeon)

2020: The announcement of Ottava - the surgical robotic platform

In the middle of November, 2020 Johnson & Johnson provided the first data on the surgical robotic Ottava platform which, according to developers, provides unsurpassed flexibility and control. A new system consists of six manipulators integrated into the operating table. The platform almost does not take the place indoors, providing comprehensive access to the patient, increases a free space in the operating room and optimizes workflow.

The development director of robotics J&J doctor Frederic Moll was a cofounder of Intuitive Surgical and joined to J&J after acquisition of his Auris Health company in 2019. It noted that it in Italian of "Ottava" means reproduction of music one octave higher, and such effect - quality at essentially new level - developers tried to obtain from the new platform. J&J considers that its platform offers more opportunities, than any other robotic system available in the market.

Johnson & Johnson submitted the surgical robotic Ottava platform

Now there is no robotic system which would provide robotic management and coordination of a full range of procedures, - the Mall noted. - My command tries to create the platform which would improve results of transactions at the broadest spectrum of diseases.

The company is going to begin verification processes and validations of the Ottava platform in 2021, and in 2022 the device will begin to participate in clinical trials. J&J is going to integrate the Ottava platform with the robotic Monarch platform which is already approved by regulatory bodies purchased at Auris Health which helps surgeons to provide low-invasive access at complex anatomic structure.

We consider Ottava as the tool of new level for the organization of operational space and optimization of surgical experience, - the Mall told.[1]

Notes